Literature DB >> 1512049

Celiac disease. A gastrointestinal disease with environmental, genetic, and immunologic components.

M F Kagnoff1.   

Abstract

In summary, research in immunogenetics, protein chemistry, and molecular biology is leading to a greater understanding of the contribution of genetic, environmental, and immunologic factors to the etiopathogenesis of celiac disease. Taken together, the findings discussed in this article suggest that understanding of the contribution of a major genetic factor to celiac disease susceptibility is closer at hand. Thus, the pathogenesis of celiac disease appears to involve an interaction between the gene products of the HLA class II D region on chromosome 6 and the gliadin proteins, possibly because of their homology with an intestinal viral protein. A logical extension of these findings would predict that T cells, particularly CD4 T cells, play a key role in the pathogenesis of celiac disease by virtue of their recognition of a gliadin or viral peptide in conjunction with the HLA class II D-region gene products. Nonetheless, the precise mechanisms by which the HLA class II genes and their products contribute to celiac disease is not known. Further, the precise peptide sequence in gliadin that interacts with the relevant HLA class II D-region molecule is not known. Finally, the role of CD4 T cells in the pathogenesis of celiac disease, either directly or indirectly by their ability to regulate other T-cell subsets and antibody-producing B cells, remains to be defined. The lessons learned and to be learned from celiac disease will substantially increase our understanding of the mechanisms that are important in this disease as well as in other intestinal and HLA-associated autoimmune diseases.

Entities:  

Mesh:

Year:  1992        PMID: 1512049

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  9 in total

Review 1.  Celiac disease--a worldwide problem.

Authors:  K Horvath; D I Mehta
Journal:  Indian J Pediatr       Date:  2000-10       Impact factor: 1.967

2.  Clinical presentation and incidence of complications in patients with coeliac disease diagnosed by relative screening.

Authors:  Neela Sundar; Rosemary Crimmins; Gillian Swift
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

Review 3.  Review of idiopathic pancreatitis.

Authors:  Jason Kihyuk Lee; Robert Enns
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

4.  Neuropsychiatric symptoms and celiac disease.

Authors:  Małgorzata Urban-Kowalczyk; Janusz OEmigielski; Agnieszka Gmitrowicz
Journal:  Neuropsychiatr Dis Treat       Date:  2014-10-14       Impact factor: 2.570

5.  Clinical and genetic profile of patients with seronegative coeliac disease: the natural history and response to gluten-free diet.

Authors:  Maria Pina Dore; Giovanni Mario Pes; Ivana Dettori; Vincenzo Villanacci; Alessandra Manca; Giuseppe Realdi
Journal:  BMJ Open Gastroenterol       Date:  2017-07-17

6.  The association between celiac disease and eosinophilic esophagitis in children and adults.

Authors:  Michael J Stewart; Eldon Shaffer; Stephan J Urbanski; Paul L Beck; Martin A Storr
Journal:  BMC Gastroenterol       Date:  2013-05-30       Impact factor: 3.067

7.  Remission of severe aphthous stomatitis of celiac disease with etanercept.

Authors:  Adey Hasan; Hiren Patel; Hana Saleh; George Youngberg; John Litchfield; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2013-12-24

8.  Perinatal Outcome and Long-Term Gastrointestinal Morbidity of Offspring of Women with Celiac Disease.

Authors:  Avishag Abecassis; Tamar Wainstock; Eyal Sheiner; Gali Pariente
Journal:  J Clin Med       Date:  2019-11-08       Impact factor: 4.241

Review 9.  The Progression of Celiac Disease, Diagnostic Modalities, and Treatment Options.

Authors:  Zahid Ijaz Tarar; Muhammad Usman Zafar; Umer Farooq; Omer Basar; Veysel Tahan; Ebubekir Daglilar
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.